YFM and EV reinvest in Peckforton Pharmaceuticals
YFM Equity Partners and Enterprise Ventures have joined the management in investing over £1m in portfolio company Peckforton Pharmaceuticals.
EV invested through the RisingStars Fund and Coalfields Enterprise Fund. YFM made the investment through the North West Business Investment Scheme, a private equity and venture capital regional development scheme targeted towards small businesses in the north-west region, managed by YFM.
The latest funding round will back the growth of the company, including product development and European expansion.
Debt
Royal Bank of Scotland provided senior debt to support the transaction.
Previous funding
EV first invested £250,000 in 2004. YFM invested £200,000 in 2007.
Company
Based in Crewe, Peckforton Pharmaceuticals specialises in the development, manufacture and supply of branded and generic pharmaceuticals for the GP and Hospital markets within the UK and Europe. The company, which focuses on injectable drugs, has been the primary supplier to the NHS Commercial Medicines Unit for the last five years.
People
Angela Warner is portfolio director at YFM Equity Partners. Julian Viggars is head of technology investments at EV. Paul Boulton is managing director of Peckforton.
Advisers
Equity (Enterprise Ventures) - Laytons (Legal)
More on UK / Ireland
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater